CN Patent

CN1827109A — 一种以兰洛地尔及其盐为活性成分的冻干粉针制剂及其制备工艺

Assigned to Beijing Rundekang Medical Technology Co Ltd · Expires 2006-09-06 · 20y expired

What this patent protects

本发明涉及一种以兰洛地尔及其盐为活性成分的冻干粉针制剂及其制备方法、用途。它是以兰洛地尔及其盐为药用活性成分，与药学上可接受的辅料混合形成的药用组合物，可用于手术时发生心动过速性心律失常(包括心房纤颤、心房扑动、窦性心动过速)的紧急治疗。以兰洛地尔及其盐为原料，加入一些特定的种类和比例的辅料，按照本发明所说明的技术手段制备开发成供静脉注射的冻干粉针剂。

USPTO Abstract

本发明涉及一种以兰洛地尔及其盐为活性成分的冻干粉针制剂及其制备方法、用途。它是以兰洛地尔及其盐为药用活性成分，与药学上可接受的辅料混合形成的药用组合物，可用于手术时发生心动过速性心律失常(包括心房纤颤、心房扑动、窦性心动过速)的紧急治疗。以兰洛地尔及其盐为原料，加入一些特定的种类和比例的辅料，按照本发明所说明的技术手段制备开发成供静脉注射的冻干粉针剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN1827109A
Jurisdiction
CN
Classification
—
Expires
2006-09-06
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Rundekang Medical Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.